Well Told Grants

Federal grant programs / Cancer Treatment Research

Cancer Treatment Research in Minnesota

Cancer Treatment Research (93.395) awarded $163 million to recipients in Minnesota in 90 grants from fiscal 2021 to 2025, 2.9% of the program's national total. Mayo Clinic received the most, $103 million.

By year

Grants under this program to recipients in Minnesota
Fiscal yearAwardsAmount
FY 202133$25.2 million
FY 202239$27.4 million
FY 202353$35.8 million
FY 202453$36.9 million
FY 202557$38.0 million

Recipients in Minnesota

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
Mayo ClinicNonprofits49$103 million
Regents of the University of MinnesotaColleges and universities32$52.5 million
Luminary Therapeutics, Inc.Small businesses3$2.7 million
Quench Medical Inc.Small businesses2$2.3 million
Emmyon, Inc.Small businesses1$2.0 million
Children's Health CareNonprofits1$408,498
Lifengine Animal Health Laboratories IncorporatedSmall businesses1$400,000
Recombinetics IncSmall businesses1$297,931

Counted by the recipient's location. A recipient based in Minnesota may carry out the work elsewhere.

Open opportunities under this program

See all 47 on the program page

Questions people ask

How much Cancer Treatment Research money goes to Minnesota?

$163 million from fiscal 2021 to 2025, across 90 awards. Minnesota ranks 10th of 50 states and territories for this program.

Who receives Cancer Treatment Research money in Minnesota?

The largest recipient is Mayo Clinic, with $103 million in 49 awards. Next are Regents of the University of Minnesota and Luminary Therapeutics, Inc..

Can organizations in Minnesota apply now?

Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Cancer Treatment Research in other states

Other large programs in Minnesota

All federal grants in Minnesota

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.